HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.

AbstractPURPOSE OF REVIEW:
Clomifene citrate is the first and the most used agent for inducing ovulation in patients affected by polycystic ovary syndrome (PCOS). About 60-85% of PCOS women ovulated under clomifene citrate, whereas the others were defined clomifene citrate-resistant. The purpose of the current review will be to describe treatment strategies to induce ovulation in infertile PCOS patients with clomifene citrate resistance.
RECENT FINDINGS:
Clomifene citrate and metformin association are a valid option for inducing ovulation in clomifene citrate-resistant PCOS patients. Surgical ovulation induction by laparoscopic ovarian drilling should be reserved to well selected cases. Excellent preliminary results are obtained using new drug formulations, such as aromatase inhibitors.
SUMMARY:
In clomifene citrate-resistant PCOS patients, clomifene citrate and metformin combination and laparoscopic ovarian drilling, in selected cases, should be considered before gonadotropin administration. The efficacy of the other treatments must be confirmed in future well designed studies.
AuthorsStefano Palomba, Angela Falbo, Fulvio Zullo
JournalCurrent opinion in obstetrics & gynecology (Curr Opin Obstet Gynecol) Vol. 21 Issue 6 Pg. 465-73 (Dec 2009) ISSN: 1473-656X [Electronic] England
PMID19809318 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Fertility Agents, Female
  • Free Radical Scavengers
  • Glucocorticoids
  • Gonadotropins
  • Hormone Antagonists
  • Hypoglycemic Agents
  • Narcotic Antagonists
  • Clomiphene
  • Gonadotropin-Releasing Hormone
  • Bromocriptine
  • Naltrexone
  • Dexamethasone
  • Metformin
  • Octreotide
  • Acetylcysteine
Topics
  • Acetylcysteine (therapeutic use)
  • Antineoplastic Agents, Hormonal (therapeutic use)
  • Aromatase Inhibitors (therapeutic use)
  • Bromocriptine (therapeutic use)
  • Clomiphene (therapeutic use)
  • Dexamethasone (therapeutic use)
  • Drug Resistance
  • Female
  • Fertility Agents, Female (therapeutic use)
  • Free Radical Scavengers (therapeutic use)
  • Glucocorticoids (therapeutic use)
  • Gonadotropin-Releasing Hormone (therapeutic use)
  • Gonadotropins (therapeutic use)
  • Hormone Antagonists (therapeutic use)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Infertility, Female (etiology, therapy)
  • Laparoscopy
  • Metformin (therapeutic use)
  • Naltrexone (therapeutic use)
  • Narcotic Antagonists (therapeutic use)
  • Octreotide (therapeutic use)
  • Ovary (surgery)
  • Ovulation Induction (methods)
  • Polycystic Ovary Syndrome (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: